- BNF:
- 2.5.1
- Status:
- Red
- Decision Date:
- None
Comments
Treatment
of pulmonary arterial hypertension in adults, adolescents and children (aged ≥8
to <18 years) of WHO Functional Class II to III, including use in
combination treatment [new 2.5mg tablet formulation].
NHS England commissioned. To be used in line with NHSE commissioning intentions.
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
search again